Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Fatherhood hailed as intervention point in men's health

Fatherhood hailed as intervention point in men's health

Indeterminate Southern Highland News
Owner: Antony Catalano & Alex Waislitz
Regis Healthcare Shares Soar 16% on Australian Budget Aged Care Funding Boost

Regis Healthcare Shares Soar 16% on Australian Budget Aged Care Funding Boost

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation

ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation

Ben Roberts-Smith planned to leave Australia and researched buying wellness business in Spain, court documents show

Ben Roberts-Smith planned to leave Australia and researched buying wellness business in Spain, court documents show

NZ sharemarket dragged down by F&P Healthcare – Market close

NZ sharemarket dragged down by F&P Healthcare – Market close

Disability minister Mark Butler on the ‘necessary’ cuts to an NDIS ‘under pressure’ – Australian Politics podcast

Disability minister Mark Butler on the ‘necessary’ cuts to an NDIS ‘under pressure’ – Australian Politics podcast

Center-left The Guardian
Owner: The Scott Trust
Regis Healthcare Shares Soar 16% on Australian Budget Aged Care Funding Boost

Regis Healthcare Shares Soar 16% on Australian Budget Aged Care Funding Boost

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation

ASX 200 Top Gainers Surge as Regis Healthcare Jumps 16% on Budget Optimism and Sector Rotation

Ben Roberts-Smith planned to leave Australia and researched buying wellness business in Spain, court documents show

Ben Roberts-Smith planned to leave Australia and researched buying wellness business in Spain, court documents show

NZ sharemarket dragged down by F&P Healthcare – Market close

NZ sharemarket dragged down by F&P Healthcare – Market close

Disability minister Mark Butler on the ‘necessary’ cuts to an NDIS ‘under pressure’ – Australian Politics podcast

Disability minister Mark Butler on the ‘necessary’ cuts to an NDIS ‘under pressure’ – Australian Politics podcast

Fatherhood hailed as intervention point in men's health

Fatherhood hailed as intervention point in men's health

Show More

Video Stories

YouTube video thumbnail: Australia Post's Latest Innovation Promising to Speed up Deliveries
Play
Australia Post's Latest Innovation Promising to Speed up Deliveries
YouTube video thumbnail: Australian-First Lawsuit Over 'Extreme Heat' Risks in Remote Public Housing
Play
Australian-First Lawsuit Over 'Extreme Heat' Risks in Remote Public Housing
YouTube video thumbnail: Farmers Fear Potential Mouse Plague Amid Warning of High Numbers
Play
Farmers Fear Potential Mouse Plague Amid Warning of High Numbers
YouTube video thumbnail: Should There Be a New Tax on Australian Gas Exports?
Play
Should There Be a New Tax on Australian Gas Exports?

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions